Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Tdf 3tc'

Tdf 3tc published presentations and documents on DocSlides.

Joel E. Gallant, MD, MPH

Joel E. Gallant, MD, MPH

  • mastervisa
  • 11 Slides

Medical Director, Specialty . Services. Southwest ...

937401234123534671341849346744x 19 333133Webinar Requirements A c

937401234123534671341849346744x 19 333133Webinar Requirements A c

  • erica
  • 72 Slides

HBcAbThis prescribe ARTART Dispensed0-5-14 Days0-1...

Eric S. Daar , MD Michael S.

Eric S. Daar , MD Michael S.

  • ButterflyHeart
  • 41 Slides

Saag. , MD. Antiretroviral Therapy:. A Case-Based ...

Optimization of Antiretroviral Therapy

Optimization of Antiretroviral Therapy

  • belinda
  • 26 Slides

With Emergence of Comorbidities. Roger J. . Bedimo...

EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)

EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)

  • tawny-fly
  • 20 Slides

M Harris, . S Guillemi. , K Chan, B Yip. ,. . M ...

Switch de TDF a TAF Estudio GS-US-292-0109

Switch de TDF a TAF Estudio GS-US-292-0109

  • calandra-battersby
  • 0 Slides

Estudio GS-US-311-1089 . Estudio GS-US-366-1216 ....

Switch from TDF to TAF

Switch from TDF to TAF

  • easyho
  • 13 Slides

GS-US-292-0109 Study. GS-US-311-1089 Study. . De...

Switching to TAF from TDF, each with RPV and FTC

Switching to TAF from TDF, each with RPV and FTC

  • julia
  • 8 Slides

Study GS-366-1216. Switch from TDF to TAF, each wi...

TDF-FTC versus Placebo as HIV PrEP for Transgender Women

TDF-FTC versus Placebo as HIV PrEP for Transgender Women

  • shmuel184
  • 7 Slides

iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...

Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)

Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)

  • zane419
  • 6 Slides

Study 105. Atazanavir + [Cobicistat or Ritonavir] ...

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

  • kylo
  • 31 Slides

Andrew Hill, Francois Venter, Eric . Delaporte. , ...

Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial

Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial

  • keanu817
  • 7 Slides

RADAR Trial. Raltegravir. + Darunavir/r versus TD...

Young person with multi-class resistance: follow-up and man

Young person with multi-class resistance: follow-up and man

  • luanne-stotts
  • 52 Slides

(with perspectives from well-resourced and resour...

Rationalizing Pediatric ARV Formularies:

Rationalizing Pediatric ARV Formularies:

  • marina-yarberry
  • 28 Slides

The IATT Optimal Pediatric ARV List. . Presented...

Switch to LPV/

Switch to LPV/

  • lindy-dunigan
  • 6 Slides

r. + 3TC. OLE . Study. LPV/. r. bid + 3TC or FT...

ART Initiation in Resource-Limited Settings

ART Initiation in Resource-Limited Settings

  • lois-ondreau
  • 12 Slides

Susan M. Graham . Assistant Professor, Medicine a...

Treatment of Children and Adolescents

Treatment of Children and Adolescents

  • liane-varnes
  • 16 Slides

Implementation Challenges. Annette H. Sohn, MD. T...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

  • myesha-ticknor
  • 0 Slides

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

Monday, 23 July, 10:15-12:15

Monday, 23 July, 10:15-12:15

  • della
  • 27 Slides

Hall 11B, RAI Amsterdam. Uptake and Procurement of...

Treatment Approaches to Achieve the 2

Treatment Approaches to Achieve the 2

  • gabriella
  • 25 Slides

nd. 90: Child Friendly Formulations . Victor Mu...

What’s new in the 2019 WHO Guidelines:

What’s new in the 2019 WHO Guidelines:

  • elina
  • 32 Slides

Dolutegravir based regimens in first- ad second-li...

ADDP Training Programme Community Retail Pharmacy Drug Distribution Points

ADDP Training Programme Community Retail Pharmacy Drug Distribution Points

  • jocelyn
  • 178 Slides

(CRPDDP). Training Contents. Module 1. : . HIV Ove...

CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL THERAPY

CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL THERAPY

  • sophie
  • 22 Slides

Y. . S. un, J. Li, J. Ma, C. Wang, F. Bai, K. Zhao...

HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO

HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO

  • hazel
  • 59 Slides

Dr Laura Oyiengo. NATIONAL AIDS STI CONTROL PROGRA...

ClinicalTrials.gov

ClinicalTrials.gov

  • lauren
  • 13 Slides

Identifier: . NCT02770508 . Dual therapy based on ...

Innovative Strategies for the Management

Innovative Strategies for the Management

  • karlyn-bohler
  • 37 Slides

of HIV Infection. Dual therapies without NRTIs. J...

ART in Resource-limited settings :

ART in Resource-limited settings :

  • liane-varnes
  • 0 Slides

Progress and Challenges. Dr. B. B. . Rewari. MD,...

Comprehensive Guideline Summary

Comprehensive Guideline Summary

  • aaron
  • 0 Slides

Guidelines for the Use of Antiretroviral Agents. ...

Track B Workshop Controversies in the Management of HIV-positive Adults:

Track B Workshop Controversies in the Management of HIV-positive Adults:

  • natalia-silvester
  • 0 Slides

A Case-Based Approach. Sasisopin Kiertiburanakul,...

Highlights for clinical

Highlights for clinical

  • pasty-toler
  • 0 Slides

. practice. HIV. International Congress of Drug ...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • natalia-silvester
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

Switch to NNRTI Switch to DOR/3TC/TDF

Switch to NNRTI Switch to DOR/3TC/TDF

  • ellena-manuel
  • 0 Slides

DRIVE-SHIFT. . Study. . Design. Endpoints. Prim...

Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)

Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)

  • alida-meadow
  • 70 Slides

Treating and Preventing HIV in 2019: Interactive ...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • yoshiko-marsland
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

Michael S. Saag , MD Professor of Medicine

Michael S. Saag , MD Professor of Medicine

  • roxanne
  • 35 Slides

Associate Dean for Global Health. University of Al...

IAS – USA Fall New York Course: Case Discussion

IAS – USA Fall New York Course: Case Discussion

  • jalin
  • 61 Slides

Luke . Jerram. Disclosures: Educational grant supp...

Introduction Characteristics, Treatment Patterns,

Introduction Characteristics, Treatment Patterns,

  • cappi
  • 1 Slides

and . Virologic. Outcomes . for Treatment-experie...

ART as prevention: PEP &

ART as prevention: PEP &

  • phoebe-click
  • 143 Slides

PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...

Schéma

Schéma

  • tatiana-dople
  • 22 Slides

de . l’étude. Critère. principal . –. pu...

Phase 2 of new ARVs

Phase 2 of new ARVs

  • mitsue-stanley
  • 18 Slides

Fostemsavir. , . prodrug. of . temsavir. . (. a...

Copyright © 2024 DocSlides. All Rights Reserved